Company Overview of Alinea Pharmaceuticals, Inc.
Alinea Pharmaceuticals, Inc. develops pharmaceuticals for the treatment of diabetes and related metabolic disorders. The company’s products include Aldose Reductase Inhibitors, a rate controlling enzyme in the polyol pathway of glucose metabolism whereby excess glucose is converted into fructose and sorbitol in tissues, such as the retina, kidney, and nerves. It also offers Phosphotyrosine Phosphatase, which involves in insulin and leptin signaling and a mechanism for downregulating the insulin and leptin receptor signaling pathways. Alinea Pharmaceuticals, Inc. was founded in 2005 and is based in Cambridge, Massachusetts.
One Memorial Drive
Cambridge, MA 02142-1313
Founded in 2005
Key Executives for Alinea Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Rempex Pharmaceuticals, Inc.||United States|
|Modular Genetics, Inc.||United States|
|Micell Technologies, Inc.||United States|
|BIO-IVT Group||United States|
|Provid Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- New York, NY | AstraZenecaPosted: Dec 03
- San Francisco, CA | JobvertisePosted: Nov 30
- Parsippany, NJ | RGPPosted: Nov 27
- Detroit, MI | AstraZenecaPosted: Dec 03
Sponsored Financial Commentaries
To contact Alinea Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.